+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Insight, 2025 - Product Thumbnail Image

Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2025 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Alcohol Addiction - Pipeline Insight, 2025 - Product Thumbnail Image

Alcohol Addiction - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Acute Lung Injury - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Lung Injury - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Lactose Intolerance - Pipeline Insight, 2025 - Product Thumbnail Image

Lactose Intolerance - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Primary Biliary Cholangitis (PBC)- Pipeline Insight, 2025 - Product Thumbnail Image

Primary Biliary Cholangitis (PBC)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Chagas Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Chagas Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Proteus Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Proteus Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Graves' Ophthalmopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Graves' Ophthalmopathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Fanconi Anemia (FA) - Pipeline Insight, 2025 - Product Thumbnail Image

Fanconi Anemia (FA) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Tay-Sachs Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Tay-Sachs Disease- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Vaso-Occlusive Crisis - Pipeline Insight, 2025 - Product Thumbnail Image

Vaso-Occlusive Crisis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Paroxysmal Supraventricular Tachycardia - Pipeline Insight, 2025 - Product Thumbnail Image

Paroxysmal Supraventricular Tachycardia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
D3 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

D3 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Plasmin Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Plasmin Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
C5a Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

C5a Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
5-HT1B Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT1B Agonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Vasopressin V2 Receptor (V2R) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Vasopressin V2 Receptor (V2R) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Neurokinin 1 (NK1) Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Neurokinin 1 (NK1) Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more